Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Market indices provide a snapshot of broad performance and risk. This overview outlines why investors rely on them for benchmarking.
28,391 articlesHims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
A wealth manager reduced its position in FIXD by 86,075 shares, cutting the value by roughly $3.8 million. This artic...
Cathie Wood is famous for spotting disruptive growth. This guide breaks down what cathie wood goes bargain means and ...
February delivered a surprising 10% rise for Sandisk stock, even without a major company catalyst. This guide breaks ...
NVIDIA signals a major pivot away from China as export controls tighten and domestic AI chip ambitions surge, a move ...
ZIM shares hover near $27.54, well under Hapag-Lloyd’s $35 cash proposal. The discount reflects regulatory risk aroun...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
Broadcom's June earnings could upend market expectations. This deep-dive explains why the report may matter more than...
Ark Invest's July activity shows notable interest in Kratos Defense. This article breaks down what the buys mean, the...
I used to be skeptical about SoundHound AI, but new developments and strategic moves are making me reconsider. This a...